Abstract
There is growing interest in neuromodulatory interventions as an alternative to conventional epilepsy surgery for pediatric drug resistant epilepsy (DRE). As these new treatment options are developed, the gap in understandings and expectations between providers and potential recipients is likely to widen. We aim to close this gap via evidence-based materials that promote informed decision-making based on the values, perspectives, and priorities of all stakeholders.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
